A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein
Authors
Keywords
-
Journal
Journal of Parkinsons Disease
Volume -, Issue -, Pages 1-31
Publisher
IOS Press
Online
2018-10-31
DOI
10.3233/jpd-181471
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype
- (2018) Georgia Minakaki et al. Autophagy
- In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study
- (2018) Karoline Knudsen et al. LANCET NEUROLOGY
- Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve
- (2018) Norihito Uemura et al. Molecular Neurodegeneration
- Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
- (2018) Tanya Simuni et al. MOVEMENT DISORDERS
- Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
- (2018) Anthony E. Lang et al. MOVEMENT DISORDERS
- Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies
- (2018) Chao Peng et al. NATURE
- Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
- (2018) Fredric P. Manfredsson et al. NEUROBIOLOGY OF DISEASE
- Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
- (2018) Chao Peng et al. NEUROBIOLOGY OF DISEASE
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases
- (2018) Carlo Alberto Artusi et al. PARKINSONISM & RELATED DISORDERS
- Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic
- (2018) Ross W. Paterson et al. Alzheimers Research & Therapy
- Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in Rodents
- (2018) Nicole K. Polinski et al. Journal of Parkinsons Disease
- Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease
- (2018) Joseph Jankovic et al. JAMA Neurology
- The Parkinson Pandemic—A Call to Action
- (2018) E. Ray Dorsey et al. JAMA Neurology
- Therapeutic approaches to target alpha-synuclein pathology
- (2017) Patrik Brundin et al. EXPERIMENTAL NEUROLOGY
- Analysis of facial expressions in parkinson's disease through video-based automatic methods
- (2017) Andrea Bandini et al. JOURNAL OF NEUROSCIENCE METHODS
- Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies
- (2017) Daryl J Wile et al. LANCET NEUROLOGY
- Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy
- (2017) Fares Bassil et al. MOVEMENT DISORDERS
- Progression markers of motor deficits in Parkinson's disease: A biannual 4-year prospective study
- (2017) Sebastian Heinzel et al. MOVEMENT DISORDERS
- Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology
- (2017) Shunsuke Koga et al. MOVEMENT DISORDERS
- A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations
- (2017) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
- (2017) Jennifer L. Whitwell et al. MOVEMENT DISORDERS
- Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials
- (2017) Alberto J. Espay et al. MOVEMENT DISORDERS
- Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease
- (2017) Philipp Mahlknecht et al. MOVEMENT DISORDERS
- PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins
- (2017) Alexandra Perez-Soriano et al. MOVEMENT DISORDERS
- Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features
- (2017) Jennifer G. Goldman et al. MOVEMENT DISORDERS
- Animal models of α-synucleinopathy for Parkinson disease drug development
- (2017) James B. Koprich et al. NATURE REVIEWS NEUROSCIENCE
- Modeling Parkinson’s disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain
- (2017) Poonam Thakur et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vivo Assessment of Brainstem Depigmentation in Parkinson Disease: Potential as a Severity Marker for Multicenter Studies
- (2017) Stefan T. Schwarz et al. RADIOLOGY
- Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of α-synuclein in cerebrospinal fluid
- (2017) Niels Kruse et al. Bioanalysis
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid
- (2017) Mohammad Shahnawaz et al. JAMA Neurology
- Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson’s Disease (CAPTURE PD): Protocol for a Multicenter Study
- (2017) Timo Siepmann Frontiers in Neurology
- Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates
- (2017) Ronald J. Mandel et al. Acta Neuropathologica Communications
- Propagation of pathological α-synuclein in marmoset brain
- (2017) Aki Shimozawa et al. Acta Neuropathologica Communications
- Automated analysis of connected speech reveals early biomarkers of Parkinson’s disease in patients with rapid eye movement sleep behaviour disorder
- (2017) Jan Hlavnička et al. Scientific Reports
- CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
- (2016) Ju-Hee Kang et al. ACTA NEUROPATHOLOGICA
- Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical Trials
- (2016) Jeff Sevigny et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder
- (2016) Roberto De Marzi et al. ANNALS OF NEUROLOGY
- The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
- (2016) Anja Hviid Simonsen et al. Biomarkers in Medicine
- Analysis of recent failures of disease modifying therapies in Alzheimer’s disease suggesting a new methodology for future studies
- (2016) Hamid Reza Amanatkar et al. Expert Review of Neurotherapeutics
- Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease
- (2016) Nolwen L. Rey et al. JOURNAL OF EXPERIMENTAL MEDICINE
- How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
- (2016) Laura A. Volpicelli-Daley et al. JOURNAL OF NEUROCHEMISTRY
- Molecular changes in the postmortem parkinsonian brain
- (2016) Damien Toulorge et al. JOURNAL OF NEUROCHEMISTRY
- Blood Biomarkers for Alzheimer’s Disease: Much Promise, Cautious Progress
- (2016) Ashvini Keshavan et al. Molecular Diagnosis & Therapy
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
- (2016) Nour K. Majbour et al. Molecular Neurodegeneration
- Twelve-week sensor assessment in Parkinson's disease: Impact on quality of life
- (2016) Janet M.T. van Uem et al. MOVEMENT DISORDERS
- New methods for the assessment of Parkinson's disease (2005 to 2015): A systematic review
- (2016) Álvaro Sánchez-Ferro et al. MOVEMENT DISORDERS
- Free-living monitoring of Parkinson's disease: Lessons from the field
- (2016) Silvia Del Din et al. MOVEMENT DISORDERS
- Technology in Parkinson's disease: Challenges and opportunities
- (2016) Alberto J. Espay et al. MOVEMENT DISORDERS
- Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression
- (2016) Frank Soldner et al. NATURE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Advances in markers of prodromal Parkinson disease
- (2016) Ronald B. Postuma et al. Nature Reviews Neurology
- Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration
- (2016) Robin Wolz et al. NEUROLOGY
- Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein
- (2016) N. L. Rey et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson’s disease
- (2016) Keita Matsuura et al. NEUROSCIENCE LETTERS
- Alpha-synuclein-based models of Parkinson's disease
- (2016) B. Dehay et al. REVUE NEUROLOGIQUE
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity
- (2016) Kelvin C. Luk et al. Cell Reports
- Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
- (2016) Ioannis U. Isaias et al. Frontiers in Aging Neuroscience
- Prevalence of Submandibular Gland Synucleinopathy in Parkinson’s Disease, Dementia with Lewy Bodies and other Lewy Body Disorders
- (2016) Thomas G. Beach et al. Journal of Parkinsons Disease
- Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
- (2016) Abid Oueslati Journal of Parkinsons Disease
- Analysis of recent failures of disease modifying therapies in Alzheimer’s disease suggesting a new methodology for future studies
- (2016) Hamid Reza Amanatkar et al. Expert Review of Neurotherapeutics
- Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases
- (2016) Stephen N. Gomperts et al. JAMA Neurology
- The mPower study, Parkinson disease mobile data collected using ResearchKit
- (2016) Brian M. Bot et al. Scientific Data
- Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
- (2016) Graham Fairfoul et al. Annals of Clinical and Translational Neurology
- Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density
- (2016) Hiroshi Kawaguchi et al. PLoS One
- Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
- (2015) Michael W. Weiner et al. Alzheimers & Dementia
- Longitudinal changes in free-water within the substantia nigra of Parkinson’s disease
- (2015) Edward Ofori et al. BRAIN
- Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study
- (2015) Elijah Mak et al. BRAIN
- The pattern of gray matter atrophy in Parkinson’s disease differs in cortical and subcortical regions
- (2015) Mechelle M. Lewis et al. JOURNAL OF NEUROLOGY
- Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease
- (2015) Yu Zhang et al. MOVEMENT DISORDERS
- Quantitative susceptibility mapping of the midbrain in Parkinson's disease
- (2015) Guangwei Du et al. MOVEMENT DISORDERS
- Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review
- (2015) Myria Petrou et al. MOVEMENT DISORDERS
- Alpha-synuclein propagation: New insights from animal models
- (2015) Benjamin Dehay et al. MOVEMENT DISORDERS
- α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
- (2015) W. Peelaerts et al. NATURE
- The case for rejecting the amyloid cascade hypothesis
- (2015) Karl Herrup NATURE NEUROSCIENCE
- Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration
- (2015) Katrina L. Paumier et al. NEUROBIOLOGY OF DISEASE
- Putaminal serotonergic innervation
- (2015) Jee-Young Lee et al. NEUROLOGY
- CSF proteins and resting-state functional connectivity in Parkinson disease
- (2015) M. C. Campbell et al. NEUROLOGY
- Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson’s Disease
- (2015) Suaad Abd-Elhadi et al. Scientific Reports
- Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease 1
- (2015) Diane Stephenson et al. Journal of Parkinsons Disease
- Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases
- (2015) Ronald Melki Journal of Parkinsons Disease
- Network structure of brain atrophy in de novo Parkinson's disease
- (2015) Yashar Zeighami et al. eLife
- Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
- (2015) Tessandra Stewart et al. Acta Neuropathologica Communications
- Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease
- (2015) Yuko Koshimori et al. PLoS One
- Physical Performance and Physical Activity in Older Adults: Associated but Separate Domains of Physical Function in Old Age
- (2015) Rob C. van Lummel et al. PLoS One
- A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease
- (2014) Eric Karran et al. ANNALS OF NEUROLOGY
- Scientific and Regulatory Reasons for Delay and Denial of FDA Approval of Initial Applications for New Drugs, 2000-2012
- (2014) Leonard V. Sacks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients
- (2014) Marios Politis et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular Imaging Insights into Neurodegeneration: Focus on -Synuclein Radiotracers
- (2014) M. Shah et al. JOURNAL OF NUCLEAR MEDICINE
- In Vivo Imaging of Human Cholinergic Nerve Terminals with (-)-5-18F-Fluoroethoxybenzovesamicol: Biodistribution, Dosimetry, and Tracer Kinetic Analyses
- (2014) M. Petrou et al. JOURNAL OF NUCLEAR MEDICINE
- Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts
- (2014) Julia Kraemmer et al. MOVEMENT DISORDERS
- Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
- (2014) Mike A Nalls et al. NATURE GENETICS
- Functional connectivity and cognitive decline over 3 years in Parkinson disease
- (2014) K. T. E. Olde Dubbelink et al. NEUROLOGY
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
- (2014) Reisa Sperling et al. NEURON
- Intramuscular injection of -synuclein induces CNS -synuclein pathology and a rapid-onset motor phenotype in transgenic mice
- (2014) A. N. Sacino et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β
- (2014) Jeremy H Toyn et al. Alzheimers Research & Therapy
- Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-Synuclein
- (2014) Xiang Zhang et al. Applied Sciences-Basel
- Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice
- (2013) Nolwen L. Rey et al. ACTA NEUROPATHOLOGICA
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers
- (2013) Avner Thaler et al. CORTEX
- Cholinergic Dysfunction in Parkinson’s Disease
- (2013) Martijn L. T. M. Müller et al. Current Neurology and Neuroscience Reports
- rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration
- (2013) Marusela Oliveras-Salvá et al. Molecular Neurodegeneration
- The current and projected economic burden of Parkinson's disease in the United States
- (2013) Stacey L. Kowal et al. MOVEMENT DISORDERS
- The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related Dementia
- (2013) Yaroslau Compta et al. Neurodegenerative Diseases
- Parkinson's disease cognitive network correlates with caudate dopamine
- (2013) Martin Niethammer et al. NEUROIMAGE
- Visualization of nigrosome 1 and its loss in PD: Pathoanatomical correlation and in vivo 7 T MRI
- (2013) A. I. Blazejewska et al. NEUROLOGY
- Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent
- (2013) Devika P. Bagchi et al. PLoS One
- Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease
- (2013) Shyra J. Gardai et al. PLoS One
- Validation of nigrostriatal positron emission tomography measures: Critical limits
- (2012) Morvarid Karimi et al. ANNALS OF NEUROLOGY
- Pervasive Ocular Tremor in Patients With Parkinson Disease
- (2012) George T. Gitchel et al. ARCHIVES OF NEUROLOGY
- Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonism
- (2012) B. F. L. van Nuenen et al. BRAIN
- How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder
- (2012) R. B. Postuma et al. BRAIN
- Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
- (2012) Kelvin C. Luk et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: A PET, histological and biochemical study
- (2012) J. Blesa et al. NEUROBIOLOGY OF DISEASE
- Animal models of the non-motor features of Parkinson's disease
- (2012) Kimberly McDowell et al. NEUROBIOLOGY OF DISEASE
- Impaired neurotransmission caused by overexpression of -synuclein in nigral dopamine neurons
- (2012) M. Lundblad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathological -Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
- (2012) K. C. Luk et al. SCIENCE
- Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease
- (2011) Vikas Kotagal et al. ANNALS OF NEUROLOGY
- Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease
- (2011) Ramachandiran Nandhagopal et al. BRAIN
- An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28
- (2011) David R Owen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Parkinson's disease and α-synuclein expression
- (2011) Michael J. Devine et al. MOVEMENT DISORDERS
- Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons
- (2011) M. Decressac et al. NEUROBIOLOGY OF DISEASE
- The Parkinson Progression Marker Initiative (PPMI)
- (2011) Kenneth Marek et al. PROGRESS IN NEUROBIOLOGY
- Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease
- (2010) N. I. Bohnen et al. BRAIN
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis
- (2010) Chris C Tang et al. LANCET NEUROLOGY
- Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease
- (2010) Shigeki Hirano et al. MOVEMENT DISORDERS
- Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures
- (2010) M. Politis et al. NEUROLOGY
- Dysfunction of the Default Mode Network in Parkinson Disease
- (2009) Thilo van Eimeren et al. ARCHIVES OF NEUROLOGY
- Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
- (2009) R. Nandhagopal et al. BRAIN
- In vitro characterisation of BF227 binding to α-synuclein/Lewy bodies
- (2009) Michelle T. Fodero-Tavoletti et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV -Synucleinopathy
- (2009) C. Y. Chung et al. JOURNAL OF NEUROSCIENCE
- A longitudinal program for biomarker development in Parkinson's disease: A feasibility study
- (2009) Bernard Ravina et al. MOVEMENT DISORDERS
- History of falls in Parkinson disease is associated with reduced cholinergic activity
- (2009) N. I. Bohnen et al. NEUROLOGY
- High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease
- (2009) D. E. Vaillancourt et al. NEUROLOGY
- Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
- (2008) Shaji Theodore et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Comparison of a timed motor test battery to the Unified Parkinson's Disease Rating Scale-III in Parkinson's disease
- (2008) Charlotte A. Haaxma et al. MOVEMENT DISORDERS
- Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB
- (2008) Isabelle Boileau et al. MOVEMENT DISORDERS
- Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood
- (2008) Robin Barbour et al. Neurodegenerative Diseases
- Midbrain iron content in early Parkinson disease: A potential biomarker of disease status
- (2008) W. R. W. Martin et al. NEUROLOGY
- In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease?
- (2007) Marie-Francoise Chesselet EXPERIMENTAL NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now